Immunocore Holdings (IMCR) EBT Margin (2021 - 2026)
Immunocore Holdings (IMCR) reported EBT Margin of -0.44% for Q2 2026, up 9.45 percentage points from -9.90% a year earlier but down 12.88 percentage points from the prior quarter.
Immunocore Holdings (IMCR) EBT Margin (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Immunocore Holdings' EBT Margin came in at -0.63%, up 5.64 percentage points year-over-year; for FY2025, it came in at -4.77%, up 12.29 percentage points from FY2024.
- EBT Margin has a five-year change of +285.32 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at -17.07% in FY2024 (+7.35 pp), -24.41% in FY2023 (-0.96 pp), -23.45% in FY2022 (+469.59 pp) and -493.04% in FY2021 (-202.94 pp).
- Five-year quarterly EBT Margin spans a low of -594.19% in Q4 2021 and a high of 12.44% in Q1 2026.
- Year over year, EBT Margin has now increased in each of the last three quarters, with an average year-over-year change of +10.02 percentage points over the last eight quarters.
- The high point for year-over-year EBT Margin in five years was Q3 2022 (a gain of 556.64 percentage points); the low point was Q3 2023 (a drop of 10.97 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 12.44% (Q1 2026), -15.12% (Q4 2025) and 0.29% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Immunocore Holdings | 1.58 Bn | -1.90 Bn | 114.84 Mn | -0.44% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.44% |
| Mar 31, 2026 | 12.44% |
| Dec 31, 2025 | -15.12% |
| Sep 30, 2025 | 0.29% |
| Jun 30, 2025 | -9.90% |
| Mar 31, 2025 | 6.48% |
| Dec 31, 2024 | -29.53% |
| Sep 30, 2024 | 7.59% |
| Jun 30, 2024 | -13.44% |
| Mar 31, 2024 | -34.15% |
| Dec 31, 2023 | -36.55% |
| Sep 30, 2023 | 1.13% |
| Jun 30, 2023 | -28.15% |
| Mar 31, 2023 | -35.05% |
| Dec 31, 2022 | -48.01% |
| Sep 30, 2022 | 12.10% |
| Jun 30, 2022 | -55.57% |
| Dec 31, 2021 | -594.19% |
| Sep 30, 2021 | -544.55% |
Immunocore Holdings EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=IMCR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "IMCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=IMCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();